World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12605000628640
Date of registration: 12/10/2005
Prospective Registration: No
Primary sponsor: A/Prof Claire Wainwright
Public title: Acquisition and transmission of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis
Scientific title: Acquisition and transmission of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis
Date of first enrolment: 06/10/2005
Target sample size: 20
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12605000628640.aspx
Study type:  Observational
Study design:  Purpose: Natural history;Duration: Longitudinal;Selection: Defined population;Timing: Prospective;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Prof Claire Wainwright   
Address:  5a Respiratory & Sleep Medicine Lady Cilento Children's Hospital Brisbane Australia
Telephone: +617 30681111
Email: Claire.Wainwright@health.qld.gov.au
Affiliation: 
Name: Ms Ms Joyce Cheney   
Address:  5a Respiratory & Sleep Medicine Lady Cilento Children's Hospital Brisbane Australia
Telephone: +617 30697195
Email: Joyce.Cheney@health.qld.gov.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Children and adults diagnosed with cystic fibrosis at Royal Children's Hospital, Brisbane and The Prince Charles Hospital, Brisbane Informed consent from patients or parents/guardians.
Exclusion criteria: Informed consent cannot be obtained.

Age minimum: Not stated
Age maximum: Not stated
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Human Genetics and Inherited Disorders - Cystic fibrosis
Cystic Fibrosis;
Cystic Fibrosis
Intervention(s)
This project is divided into four parts. Part one is designed to examine whether early acquisition of P.aeruginosa in young children with CF is associated with environmental sources of P.aeruginosa in the home. Part two is a methodology study designed to screen large numbers of microbiological samples for the predominant Brisbane clonal strain of P.aeruginosa. Part three allows an opportunity to explore the possible relationship between molecular factors that may be involved in acquisition and transmission of clonal strains of P.aeruginosa. Part four examines culturable cough generated aerosols in patients with CF and an examination of clinical factors that may be involved in aerosol transmission of P.aeruginosa. It is anticipated that environmental sampling may take up to 2 years to complete and that clinical air sampling will take up to 12 months to complete.
Primary Outcome(s)
To identify if aerosol contamination in the home environment provides the most likely source of P.aeruginosa for initial infection with P. aeruginosa[At time of testing]
To determine if transmission of P. aeruginosa is related to exposure time and infective load of aerosolised P. aeruginosa and specific virulence factors associated with the organism.[At time of testing]
Secondary Outcome(s)
To provide practical solutions that will contain the risks of cross-infection and enable appropriate and optimal management of all patients with CF.[At time of analysis]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
RCH Foundation, Brisbane
Secondary Sponsor(s)
Dr Scott Bell
Ethics review
Status: Approved
Approval date:
Contact:
Royal Children's Hospital
Status: Not approved
Approval date:
Contact:
The Prince Charles Hospital
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history